ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ultomiris 1100 mg/11 ml, Konzentrat zur Herstellung einer Infusionslösung - 
67278003 Alexion Pharma GmbH
Ultomiris 1100 mg/11 ml, Konzentrat zur Herstellung einer Infusionslösung20.01.2020
  16.09.2021
Ravulizumab (L04AA43) 
WHO-DDD 
07.15. 
07.15. 
A  
Yes 
IP 
14797.24Yes
    
10 %15223.00
7680672780030Biotechnologika
  
Composition
ravulizumabum 1100 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 11 ml corresp. natrium 16.8 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Ravulizumabum1100mg / 11ml
BAG: Active AgentDose
Ravulizumabum1100 mg
 
Inactive agents
Arginine
Disodium Phosphate
Natrii Dihydrogenophosphas
Polysorbatum 80
Saccharum
 
Source
Data was imported : 05.09.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home